MAY 14: MEMPHIS DAILY NEWS: Memphis company GTx expects to receive approval from the US Food and Drug Administration on Octopber 30 to begin selling a drug to prevent bone fractures in men undergoing hormone therapy to treat bone cancer. The company also has other drugs in the pipeline related to the prevention and treatment of prostate cancer and to build body mass in people with cancer-induced muscle loss. READ MORE>
PROSTATE DRUGS: Approval soon for drug to prevent bone fracture in cancer patients
May 14, 2009 by Jim Tucker
Posted in Bone cancer, Hormone therapy, New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news | Tagged advanced prostate cancer, body mass, Bone cancer, bone fractures in men undergoing hormone therapy, cancer research, cancer-induced muscle loss, Memphis company GTx, MEMPHIS DAILY NEWS, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer drugs, prostate cancer treatments, prostate treatment, prostate treatment debate, U.S. Food and Drug Administration | Leave a Comment
Blog Stats
- 295,393 hits
Search
MY PROSTATE STORY
Prostate inquiry
Prostate websites
Prostablog RSS – click here
- Still here, still clear – 2020 June 24, 2020
- PSA treachery hits close to home May 18, 2019
- Coming up to a decade clear June 4, 2018
PROSTABLOG pages
Category cloud
AFTER EFFECTS Biochemical recurrence Biopsy Brachytherapy Checkups Diagnosis Dietary intervention Doctors' advice Erectile function FUND RAISING Govt prostate policy Hormone therapy Incontinence Natural remedies New prostate drugs New tests Prostate blogs PROSTATE CANCER Prostate claims Prostate prognosis PROSTATE RESEARCH PROSTATE RISKS PSA tests Public health system Radical prostatectomy Radiotherapy Rowing 4 Prostate Screening debate Treatment debate Treatment newsCOMMENTS
Leave a Reply